Nuvectis Pharma, Inc. Share Price & Technical Analysis
NVCT · $10.35 (-5.39%)
Healthcare / Biotechnology
$10.35
-5.39%
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was former…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
21% return in May, 8% avg return in past 3 year May month.
35% return in 2026, 21% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 5% | 10% | -11% | 10% | 21% | – | – | – | – | – | – | – | 35% |
| 25 | 26% | -1% | 48% | 4% | -4% | -20% | -4% | -4% | -8% | 12% | -7% | 23% | 63% |
| 24 | -13% | 34% | -19% | -27% | 10% | -7% | -2% | 8% | -9% | 19% | -33% | 8% | -32% |
| 23 | 32% | 19% | 17% | 14% | 18% | -9% | -12% | 3% | -10% | -32% | -2% | -3% | 33% |
| 22 | – | 73% | 10% | 28% | 56% | -25% | -20% | -11% | -12% | -9% | 4% | 0% | 94% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$282.50M
P/E ratio
—
52W high
$13.34
52W low
$5.55
Volume
1,57,446
Beta
-0.12
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Nuvectis Pharma, Inc. share price today?
- Nuvectis Pharma, Inc. (NVCT) last traded around $10.35 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NVCT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NVCT. Download the app for real-time alerts.
- How can I analyze Nuvectis Pharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.